Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Marchex (MCHX) Common Equity (2016 - 2025)

Marchex (MCHX) has disclosed Common Equity for 16 consecutive years, with $31.9 million as the latest value for Q3 2025.

  • On a quarterly basis, Common Equity fell 6.37% to $31.9 million in Q3 2025 year-over-year; TTM through Sep 2025 was $31.9 million, a 6.37% decrease, with the full-year FY2024 number at $32.6 million, down 9.02% from a year prior.
  • Common Equity was $31.9 million for Q3 2025 at Marchex, roughly flat from $32.0 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $52.6 million in Q3 2021 to a low of $31.4 million in Q1 2025.
  • A 5-year average of $40.9 million and a median of $38.4 million in 2023 define the central range for Common Equity.
  • Peak YoY movement for Common Equity: tumbled 36.69% in 2021, then rose 5.19% in 2022.
  • Marchex's Common Equity stood at $51.5 million in 2021, then fell by 14.35% to $44.1 million in 2022, then decreased by 18.68% to $35.9 million in 2023, then fell by 9.02% to $32.6 million in 2024, then decreased by 2.12% to $31.9 million in 2025.
  • Per Business Quant, the three most recent readings for MCHX's Common Equity are $31.9 million (Q3 2025), $32.0 million (Q2 2025), and $31.4 million (Q1 2025).